U.S. Supreme Court justices seemed reluctant Monday to give the pharmaceutical company Merck & Co. a “statute of limitations” way out of defending against a securities fraud class action involving Vioxx. The Court heard arguments in the latest round in a continuing battle over how easy or hard it should be to file class actions. Companies want speed, while shareholder and consumer groups insist
Vioxx replacement has heart risks, studies find
Merck & Co.'s experimental painkiller, Arcoxia, may carry the same risk of heart attacks and strokes as Vioxx, according to an analysis of 23 studies comparing side effects of several pain medicines.
Midwest's first Vioxx trial set to begin
EDWARDSVILLE, Ill. The Midwest's first trial over the one-time blockbuster painkiller Vioxx is poised to begin in Madison County.
Vioxx Study, 1/4 of Patients Suffered Heart Attacks
New research shows the painkiller Vioxx can cause a heart attack within two weeks of taking the drug.
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved